PATENTS
| Title | Description | ||
|---|---|---|---|
US | |||
|
Tolvaptan API process Ref. Number: US9428461B2 (dtd. 30 Dec, 2016) |
Patent application no. US 2015/O112059A1 (dtd.20 Dec, 2014) | ||
|
Clopidogrel Free base process Ref. Number: US8063217B2 (dtd. 22 Dec, 2011) |
Patent application no. US 201O/OOO4453A1 (dtd.20 Dec, 2007) | ||
India | |||
|
Novel Formulation of Alpha Ketoanalogue Ref. Number: 324347 (dtd. 01 Dec, 2019) |
Patent application no. 1154/MUM/2011 (dtd.06 Dec, 2011) | ||
|
Tolvaptan (API)Intermediate Ref. Number: 304391 (dtd. 13 Dec, 2018) |
Patent application no. 3295/MUM/2013 (dtd.21 Dec, 2013) | ||
|
Clopidogrel Bisulphate form 1 API process Ref. Number: 298954 (dtd. 18 Dec, 2018) |
Patent application no. 758/MUM/2010 (dtd.22 Dec, 2010) | ||
|
S(+) clopidogrel free base process Ref. Number: 252835 (dtd. 04 Dec, 2012) |
Patent application no. 836/MUM/2005 (dtd.12 Dec, 2005) | ||
|
Pantoprazole sodium sesquihydrate API process Ref. Number: 238641 (dtd. 15 Dec, 2010) |
Patent application no. 551/MUM/2005 (dtd.04 Dec, 2005) | ||
|
Lamotrigine Dispersible & Meltable Tablet process Ref. Number: 219025 (dtd. 21 Dec, 2008) |
Patent application no. 419/MUM/2004 (dtd.06 Dec, 2004) | ||
|
Cyclosporine formulation process Ref. Number: 203188 (dtd. 07 Dec, 2006) |
Patent application no. 254/MUMNP/2003 (dtd.24 Dec, 2003) | ||
|
Risperidon API process Ref. Number: 196155 (dtd. 04 Dec, 2005) |
Patent application no. IN/PCT/2002/01520/MUM (dtd.30 Dec, 2002) | ||